Delivery Order SPE2DB22D2007-SPE2DB24FJ0GW
Award Date
3/7/24
Potential Completion Date
3/28/24
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 840 mg/14 mL vials of the drug TECENTRIQ. The contract has a potential value of $24,048.90 and a period of performance through March 25, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which does not have any set-aside designation. Additionally,...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML. The $8,504.62 firm-fixed-price contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,016.30, is for the delivery of Tecentriq 840 mg/14 ml vials. It is a firm fixed-price delivery order contract with a completion date of December 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The Defense Logistics Agency awarded a $7,857.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561918282 TECENTRIQ 840 MG/14 ML VIAL 14ML pharmaceutical products. Amerisourcebergen Drug Corporation will deliver the products to a location in Conshohocken, Pennsylvania by September 14, 2023 under the terms of the order. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an award ceiling value of $8,504.62 and a period of performance through February 13, 2025. The contract is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tecentriq 840 mg/14 ml vials. The contract award, valued at $12,024.45, was made by the Defense Logistics Agency (DLA) on October 16, 2024, with a completion date of November 6, 2024. This is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency awarded a $7,857.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of TECENTRIQ 840 MG/14 ML vials. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the product from its location in Conshohocken, Pennsylvania to the Defense Logistics Agency by August 29, 2023 to fulfill requirements under the agency's pharmaceutical supply contracts. No subcontractors or set aside designations were...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAST8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the provision of 4567766034 ! TECENTRIQ 840 MG/14 ML VIAL 14ML, with a ceiling value of $8,504.62 and an ultimate completion date of April 22, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $16,032.60 Firm Fixed Price Delivery Order contract is for the supply of 840 mg/14 ml vials of the cancer medication Tecentriq. The contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award, with an ID of SPE2DX15D1022|SPE2DX22F5HFS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $75,341.62 firm fixed-price delivery order is for the supply of 840 mg/14 ml vials of the drug Tecentriq. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...